Cargando…
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
SIMPLE SUMMARY: Despite recent progress in the treatment of metastatic colorectal cancer patients, novel therapeutic approaches are highly warranted to further improve outcome. Additionally, it is of utmost importance to define subgroups of patients who may derive the most benefit from a specific tr...
Autores principales: | Puccini, Alberto, Seeber, Andreas, Berger, Martin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564318/ https://www.ncbi.nlm.nih.gov/pubmed/36230751 http://dx.doi.org/10.3390/cancers14194828 |
Ejemplares similares
-
Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives
por: Mukherji, Reetu, et al.
Publicado: (2020) -
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023) -
Myconanotechnology in veterinary sector: Status quo and future perspectives
por: Hanafy, Mai Hamed
Publicado: (2018) -
Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016) -
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020)